Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026)

Phibro Animal Health's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $129.4 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 935.33% year-over-year to $129.4 million in Q1 2026; TTM through Mar 2026 was $129.4 million, a 935.33% increase from a year earlier, with the FY2025 full-year figure at $139.0 million, up 56.58% from the prior year.
• Accumulated Expenses advanced to $129.4 million in Q1 2026 per PAHC's latest filing, from $44.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $139.0 million in Q2 2025 and bottomed at $3.4 million in Q3 2023.
• The 5-year median for Accumulated Expenses is $29.4 million (2023), against an average of $48.6 million.
• Across the five-year window, Accumulated Expenses jumped 7160.44% in 2022 and tumbled 94.99% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $71.7 million in 2022, then slumped by 61.73% to $27.4 million in 2023, then tumbled by 48.01% to $14.3 million in 2024, then jumped by 209.32% to $44.1 million in 2025, then jumped by 193.38% to $129.4 million in 2026.
• Per Business Quant, the three latest PAHC Accumulated Expenses figures stand at $129.4 million (Q1 2026), $44.1 million (Q4 2025), and $20.8 million (Q3 2025).